Delta Life Science is heading to BIO-Europe 2026 in Cologne

BIO-Europe returns to Koelnmesse in Cologne from 9 to 11 November, bringing more than 8,000 life sciences professionals together around one-to-one meetings between companies, investors and licensing teams. Delta Life Science will be there.

Partnering conversations eventually reach the data. Whether a lead series is worth licensing, whether a fragment based drug discovery campaign produced real hits, whether a binding claim holds up under scrutiny. Those answers come from an instrument, and the instrument shapes what you can credibly claim.

You might have heard of surface plasmon resonance. But do you know about nanophotonic evanescent field sensing? inQuiQ brings photonics technology to label-free biosensing, giving a new route that adds high-sensitivity multiplexing to the affinity and kinetic answers SPR technology has delivered for thirty years.

That difference matters at the point where a partner or an acquirer asks how the numbers were generated. Our inQuiQ platform was built for teams who need binding data that stands up to due diligence, and our application pages show how it performs across the molecule classes most often on the table at BIO-Europe.

If you are in Cologne and want to see how the technology fits your discovery pipeline, book a meeting with us.